EUVIMEDEUVIMED entdecken
KommentarLeserbrief

Response to Dr Urata’s Letter to the Editor of Modern Rheumatology regarding a study of “Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders”

Kazuhisa Nakano

Modern Rheumatology · 2023

DOI: 10.1093/mr/roac135 ↗

Kurz gefasst

Kommentar in der Zeitschrift Modern Rheumatology, 2023. Verfasst von Kazuhisa Nakano. Beteiligte Einrichtung: The Department of Rheumatology, Kawasaki Medical School, Kurashiki, Japan. Hauptthemen laut MEDLINE: Rheumatology, Arthritis, Rheumatoid, Lymphoproliferative Disorders. Die Arbeit nennt 2 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RheumatologyArthritis, RheumatoidLymphoproliferative DisordersHumansMethotrexate

Substanzen

Methotrexate

Autor:innen und Institutionen

  • The Department of Rheumatology, Kawasaki Medical School, Kurashiki, Japan.
  • The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Working Group on the Rheumatoid Arthritis-associated Lymphoproliferative Disorders of the Japan College of Rheumatology.

Zitieren

APA

Nakano, K. (2023). Response to Dr Urata’s Letter to the Editor of Modern Rheumatology regarding a study of “Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders”. Modern Rheumatology. https://doi.org/10.1093/mr/roac135

Vancouver

Nakano K. Response to Dr Urata’s Letter to the Editor of Modern Rheumatology regarding a study of “Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders”. Modern Rheumatology. 2023. doi:10.1093/mr/roac135

BibTeX
@article{Nakano2023,
  author = {Nakano, Kazuhisa},
  title = {Response to Dr Urata’s Letter to the Editor of Modern Rheumatology regarding a study of “Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders”},
  journal = {Modern Rheumatology},
  year = {2023},
  doi = {10.1093/mr/roac135}
}
Kostenlos starten →